Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients – New England Journal of Medicine Editorial: The Goldilocks Time for Remdesivir — Is Any Indication Just Right? Commentary: Three days of remdesivir cuts risk for severe COVID-19 in outpatients – MedicalXpress   Commentary on Twitter Among nonhospitalized patients with Covid-19–related symptoms, a 3-day course […]

The post RCT: Early Remdesivir in outpatients can prevent progression to severe Covid-19. appeared first on Links Medicus.